Aurora Cannabis (ACB) Other Working Capital Changes (2017 - 2018)
Aurora Cannabis (ACB) posted quarterly Other Working Capital Changes of $5.7 million for Q4 2024, up 279.96% year-over-year from $1.5 million in Q1 2024, and up 410.31% quarter-over-quarter from -$1.8 million in Q2 2024.
Aurora Cannabis (ACB) Other Working Capital Changes (2017 - 2018) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Working Capital Changes for 2 consecutive years, with -$6.7 million the latest figure, recorded in Q4 2018.
- In Q4 2024, Other Working Capital Changes rose 279.96% year-over-year to $5.7 million; the TTM figure through Dec 2024 stood at -$8.6 million (up 48.42% YoY), while the FY2023 annual figure was -$83378.7, up 99.73% from the prior year.
- Other Working Capital Changes climbed to $5.7 million in Q4 2024 per ACB's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $35.4 million in Q1 2020 and bottomed at -$22.8 million in Q3 2021.
- Historically, Other Working Capital Changes has averaged -$1.4 million across 5 years, with a median of -$3.2 million in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 1535.79% in 2018 and fell as far as 5455.36% in 2018.
- Aurora Cannabis' Other Working Capital Changes stood at -$10.4 million in 2020, then surged by 67.54% to -$3.4 million in 2021, then slumped by 129.82% to -$7.7 million in 2022, then jumped by 58.98% to -$3.2 million in 2023, then jumped by 279.96% to $5.7 million in 2024.
- Business Quant data shows ACB's Other Working Capital Changes at $5.7 million in Q4 2024, -$1.8 million in Q2 2024, and -$3.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.11 Bn | 43.15 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.24 Bn | 39.59 Bn | 2.15 Bn |
| 3 | Zoetis | 31.84 Bn | 30.17 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.44 Bn | 19.78 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.06 Bn | 9.89 Bn | - |
| 10 | Aurora Cannabis | 238.08 Mn | 165.77 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -6.70 Mn |
| Dec 31, 2018 | -6.70 Mn |
| Dec 31, 2018 | -6.70 Mn |
| Sep 30, 2018 | -6.33 Mn |
| Sep 30, 2018 | -6.33 Mn |
| Sep 30, 2018 | -6.33 Mn |
| Dec 31, 2017 | 466,775.35 |
| Dec 31, 2017 | 466,775.35 |
| Dec 31, 2017 | 466,775.35 |
| Sep 30, 2017 | -114,029.11 |
| Sep 30, 2017 | -114,029.11 |
| Sep 30, 2017 | -114,029.11 |